ERBB2 and breast cancer: Inactivation of gene functions by deletion or other mechanisms commonly occurs in (1) PTEN in breast, ovarian, and endometrial cancers, and (2) p53 in HER2/neu positive breast cancers, triple negative breast cancers, and BRCA-associated breast and ovarian cancers.